BIOMAT Database Logo BIOMAT Database Logo

[Clinical effectiveness of a new thrombolytic preparation, Streptodecase]. 1985

E I Cazov, and A V Mazajev

UI MeSH Term Description Entries
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D005343 Fibrinolytic Agents Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. Antithrombic Drug,Antithrombotic Agent,Antithrombotic Agents,Fibrinolytic Agent,Fibrinolytic Drug,Thrombolytic Agent,Thrombolytic Agents,Thrombolytic Drug,Antithrombic Drugs,Fibrinolytic Drugs,Thrombolytic Drugs,Agent, Antithrombotic,Agent, Fibrinolytic,Agent, Thrombolytic,Agents, Antithrombotic,Drug, Antithrombic,Drug, Fibrinolytic,Drug, Thrombolytic,Drugs, Antithrombic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013300 Streptokinase Streptococcal fibrinolysin . An enzyme produced by hemolytic streptococci. It hydrolyzes amide linkages and serves as an activator of plasminogen. It is used in thrombolytic therapy and is used also in mixtures with streptodornase (STREPTODORNASE AND STREPTOKINASE). EC 3.4.-. Avelizin,Awelysin,Celiase,Distreptase,Kabikinase,Kabivitrum,Streptase,Streptodecase
D013927 Thrombosis Formation and development of a thrombus or blood clot in BLOOD VESSELS. Atherothrombosis,Thrombus,Blood Clot,Blood Clots,Thromboses

Related Publications

E I Cazov, and A V Mazajev
[Effect of the new Soviet thrombolytic preparation streptodecase on the fibrinolysis system].
August 1981, Kardiologiia,
E I Cazov, and A V Mazajev
[Streptodecase--a new Soviet thrombolytic long-acting agent].
January 1981, Terapevticheskii arkhiv,
E I Cazov, and A V Mazajev
[Evaluation of the effectiveness of thrombolytic therapy using streptodecase in patients with myocardial infarct].
June 1990, Kardiologiia,
E I Cazov, and A V Mazajev
[Clinical effectiveness and administration of streptodecase in patients with acute myocardial infarction].
January 1984, Terapevticheskii arkhiv,
E I Cazov, and A V Mazajev
[Clinical effectiveness of a new preparation of sustained-release theophylline].
January 1989, La Pediatria medica e chirurgica : Medical and surgical pediatrics,
E I Cazov, and A V Mazajev
[Streptokinase and streptodecase--new inhibitors of gluconeogenesis].
August 1985, Kardiologiia,
E I Cazov, and A V Mazajev
Clinical pharmacology of the thrombolytic enzyme preparation brinase.
July 1989, Seminars in thrombosis and hemostasis,
E I Cazov, and A V Mazajev
Antithrombotic and thrombolytic effects of a new proteolytic preparation Trombovazim (Russia).
April 2009, Bulletin of experimental biology and medicine,
E I Cazov, and A V Mazajev
[Effectiveness of a new anti-arrhythmic preparation--etmosine].
October 1971, Klinicheskaia meditsina,
E I Cazov, and A V Mazajev
[Pharmacological and clinical study of the thrombolytic effectiveness of ocrase].
August 1981, Kardiologiia,
Copied contents to your clipboard!